Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Von Willebrand factor

Pervinder Bhogal, Melanie Jensen, Dan Hart, Levansri Makalanda, George B Collins, Oliver Spooner and Ounali Jaffer
Download PDF
DOI: https://doi.org/10.7861/clinmed.Let.20.6.3
Clin Med November 2020
Pervinder Bhogal
The Royal London Hospital, London, UK
Roles: Consultant interventional neuroradiologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melanie Jensen
Imperial College Healthcare NHS Trust, London, UK
Roles: NIHR academic fellow in histopathology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Hart
The Royal London Hospital, London, UK
Roles: Consultant haematologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Levansri Makalanda
The Royal London Hospital, London, UK
Roles: Consultant interventional neuroradiologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George B Collins
University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Spooner
The Royal London Hospital, London, UK
Roles: Consultant stroke physician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ounali Jaffer
The Royal London Hospital, London, UK
Roles: Consultant interventional radiologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Editor – Ladikou et al have elegantly shown in their series that levels of factor VIII and von Willebrand factor (VWF) are markedly raised in patients with COVID-19 and that there is a reduced level of ADAMTS13 which may be secondary to depletion of the enzyme through consumption.1 Similar results have been reported by others and there is a growing recognition that COVID-19 may trigger a ‘thrombo-inflammatory’ cascade that should be targeted.2–5 Endothelialitis, whether caused by COVID-19 or another septic process, triggers the release of VWF, including the highly biologically active and more adhesive ultra-long VWF that can bind platelets spontaneously via glycoprotein Ib receptors. The ultra-long VWF multimers released from the Weibel–Palade bodies have a lower shear stress for unfolding and therefore may represent the initiating molecules for this self-assembly process which leads to hyper-adhesive strings capturing platelets and the microthrombosis that is now well established as part of the disease.6–10 This represents the first step in platelet activation and thrombus growth. Under normal conditions ADAMTS13 cleaves VWF and regulates the VWF/platelet interaction, however, this regulatory mechanism may be overwhelmed by the degree of microthrombosis seen in COVID-19 as is suggested by the results presented by Ladikou et al. We believe that targeting the initial VWF/platelet interaction with caplacizumab presents an attractive target that may prevent widespread microthrombosis and its clinical sequelae and that this drug may prove be particularly effective for patients that present with abnormally raised VWF, and abnormal VWF/factor VIII ratio or reduced ADAMTS13. We believe that investigation of caplacizumab in these patients warrants urgent investigation. Anfibatide represents an alternative drug with a similar mode of action to caplacizumab and should also be considered high on the list of drugs to be investigated.

  • © Royal College of Physicians 2020. All rights reserved.

References

  1. ↵
    1. Ladikou EE
    , Sivaloganathan H, Milne KM, et al. Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19? Clin Med 2020;20:e178–82.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Helms J
    , Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 2020;46:1089–98.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Goshua G
    , Pine AB, Meizlish ML, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol 2020;7:E575–82.
    OpenUrl
  4. ↵
    1. Escher R
    , Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res 2020;190:62.
    OpenUrlCrossRef
  5. ↵
    1. Guglielmetti G
    , Quaglia M, Sainaghi PP, et al. ‘War to the knife’ against thromboinflammation to protect endothelial function of COVID-19 patients. Crit Care 2020;24:365.
    OpenUrl
  6. ↵
    1. Carsana L
    , Sonzogni A, Nasr A, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis 2020;20:P1135–40.
    OpenUrl
  7. ↵
    1. Tee A
    , Wong A, Yusuff T, Rao D, Sidhu P. Contrast-enhanced ultrasound (CEUS) of the lung reveals multiple areas of microthrombi in a COVID-19 patient. Intensive Care Med 2020 [Epub ahead of print].
  8. ↵
    1. Ciceri F
    , Beretta L, Scandroglio AM, et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc 2020;22:95–7.
    OpenUrl
  9. ↵
    1. Fox SE
    , Akmatbekov A, Harbert JL, et al. Pulmonary and cardiac pathology in covid-19: the first autopsy series from New Orleans. medRxiv 2020;2020.04.06.20050575.
  10. ↵
    1. Jung EM
    , Stroszczynski C, Jung F. Contrast enhanced ultrasonography (CEUS) to detect abdominal microcirculatory disorders in severe cases of COVID-19 infection: First experience. Clin Hemorheol Microcirc 2020;74:353–61.
    OpenUrl
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Von Willebrand factor
Pervinder Bhogal, Melanie Jensen, Dan Hart, Levansri Makalanda, George B Collins, Oliver Spooner, Ounali Jaffer
Clinical Medicine Nov 2020, 20 (6) e279; DOI: 10.7861/clinmed.Let.20.6.3

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Von Willebrand factor
Pervinder Bhogal, Melanie Jensen, Dan Hart, Levansri Makalanda, George B Collins, Oliver Spooner, Ounali Jaffer
Clinical Medicine Nov 2020, 20 (6) e279; DOI: 10.7861/clinmed.Let.20.6.3
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Core medical training to internal medicine training: progress or a step backwards?
  • The association of pleural effusion and pulmonary embolism
  • Optimisation of strategies for management of heart failure with preserved ejection fraction
Show more Letters to the editor

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians